Genomatica closed $118 million in Series C funding

Christophe Schilling, CEO of Genomatica during his speech at the Grand Opening of Mater Biotech’s plant in Bottrighe di Adria, Italy

US biotech company Genomatica closed $118 million in Series C funding to accelerate the global commercialization and expansion of sustainable materials, with the potential to reduce greenhouse gas emissions by 100 million tons per year. Leading life science investor Novo Holdings led the round, with additional participation by existing and new investors including Viking Global Investors, Casdin Capital and others. Genomatica will use the investment to scale production for its portfolio of products and continue investing in new technologies to amplify the impact of sustainable materials across a range of industries.

Continue reading

3F Bio voted best speech and MetGen won the John Sime award at Efib 2016

efib-2014.jpg3F Bio and MetGen were acknowledged by their peers as industrial biotech leaders at this year’s European Forum on Industrial Biotechnology and the Bioeconomy, which was held on 18-20 October in Glasgow, Scotland,

Continue reading